{{Rsnum
|rsid=4906902
|Gene=GABRB3
|Chromosome=15
|position=26774621
|Orientation=plus
|GMAF=0.2062
|Gene_s=GABRB3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 62.8 | 30.1 | 7.1
| HCB | 44.5 | 48.2 | 7.3
| JPT | 35.4 | 54.9 | 9.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.4 | 3.6 | 0.0
| CHB | 44.5 | 48.2 | 7.3
| CHD | 52.3 | 42.2 | 5.5
| GIH | 50.0 | 40.0 | 10.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 37.9 | 43.1 | 19.0
| MKK | 99.4 | 0.6 | 0.0
| TSI | 68.6 | 28.4 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22765836
|Title=Effects on promoter activity of common SNPs in 5' region of GABRB3 exon 1A
|OA=1
}}

{{PMID Auto
|PMID=22082659
|Title=Promoter variants determine γ-aminobutyric acid homeostasis-related gene transcription in human epileptic hippocampi
}}

{{PMID Auto
|PMID=17215107
|Title=Lack of evidence of an allelic association of a functional GABRB3 exon 1a promoter polymorphism with idiopathic generalized epilepsy.
}}

{{PMID Auto
|PMID=21905019
|Title=Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia.
|OA=1
}}

{{PMID Auto
|PMID=25025424
|Title=Association Analysis of GABRB3 Promoter Variants with Heroin Dependence
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}